PlaBiTe

Arises from the developments and scientific-technological activity of the Platelet Research Group of the Health Research Institute of the Principality of Asturias (ISPA), led by Laura Gutiérrez (ISPA-UO).

PlaBiTe has developed a proprietary platelet-derived platform that enables the generation of standardized human bioproducts for biotechnology, regenerative medicine and future therapeutic applications.

Proprietary Platelet Processing Technology

At the core of PlaBiTe is our proprietary platelet processing technology, designed to unlock the biological potential of human platelets and transform it into standardized bioproducts for research, biotechnology and regenerative medicine.

From a single technological platform, we develop solutions across two complementary areas: PlaBiTe Growth® for biotechnology and cell expansion, and our therapeutic pipeline for regenerative medicine.

Plabite

Research & Biotechnology

Enabling innovation in cell culture and biotechnology applications

PlaBiTe Growth®

Human platelet-derived bioproducts for research and biotechnology.

Regenerative Medicine

Advancing solutions for tissue repair and regenerative therapies.

Therapeutic Development

Next-generation platelet-based therapeutics for regenerative medicine.

Scientific Innovation

One platelet technology. Multiple bioproducts. From research to regenerative medicine.

Human
Source

Xeno
free

Highly
Standardized

Scalable manufacturing

Science-Driven Innovation